Literature DB >> 7712589

Aspirin, NSAIDs, and digestive tract cancers.

M J Thun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7712589     DOI： 10.1007/bf00666097

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  52 in total

1.  Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; L F Watson
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

2.  A broad anticancer effect of aspirin?

Authors:  J A Baron; H O Adami
Journal:  Epidemiology       Date:  1994-03       Impact factor: 4.822

3.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

4.  Aspirin use and chronic diseases: a cohort study of the elderly.

Authors:  A Paganini-Hill; A Chao; R K Ross; B E Henderson
Journal:  BMJ       Date:  1989-11-18

5.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

Authors:  P H Gann; J E Manson; R J Glynn; J E Buring; C H Hennekens
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

6.  Sulindac for polyposis of the colon.

Authors:  W R Waddell; R W Loughry
Journal:  J Surg Oncol       Date:  1983-09       Impact factor: 3.454

7.  Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine.

Authors:  M Pollard; P H Luckert
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

8.  Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer.

Authors:  A Lipton; S Scialla; H Harvey; R Dixon; R Gordon; R Hamilton; H Ramsey; M Weltz; R Heckard; D White
Journal:  J Med       Date:  1982

9.  A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

Authors:  M Moorghen; P Ince; K J Finney; J P Sunter; D R Appleton; A J Watson
Journal:  J Pathol       Date:  1988-12       Impact factor: 7.996

10.  Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinoma.

Authors:  W J Maxwell; D Kelleher; J J Keating; F P Hogan; F J Bloomfield; G S MacDonald; P W Keeling
Journal:  Digestion       Date:  1990       Impact factor: 3.216
View more
  13 in total

1.  Cyclooxygenase-2 gene and lung carcinoma risk.

Authors:  Ender Coskunpinar; Ilhan Yaylim Eraltan; Akif Turna; Bedia Agachan
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

2.  Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.

Authors:  A Ristimäki; O Nieminen; K Saukkonen; K Hotakainen; S Nordling; C Haglund
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.

Authors:  V W Yang; D E Geiman; W C Hubbard; E W Spannhake; L M Hylind; S R Hamilton; F M Giardiello
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-01       Impact factor: 3.072

4.  Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer.

Authors:  Jan Brabender; JiMin Park; Ralf Metzger; Paul M Schneider; Reginald V Lord; Arnulf H Hölscher; Kathleen D Danenberg; Peter V Danenberg
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  Acetaminophen selectively reduces glioma cell growth and increases radiosensitivity in culture.

Authors:  D Casper; R Lekhraj; U S Yaparpalvi; A Pidel; W A Jaggernauth; P Werner; S Tribius; J D Rowe; P A LaSala
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

6.  Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats.

Authors:  C J Barnes; W E Hardman; I L Cameron; M Lee
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

7.  Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.

Authors:  Z Dong; C Huang; R E Brown; W Y Ma
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

8.  Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma.

Authors:  C N Chen; C T Sung; M T Lin; P H Lee; K J Chang
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

9.  Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac.

Authors:  Michele T Yip-Schneider; Chad A Wiesenauer; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

10.  The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer.

Authors:  Thomas E Adrian; Rene Hennig; Helmut Friess; Xianzhong Ding
Journal:  PPAR Res       Date:  2009-01-27       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.